A Vascular Surgeon Plays a Critical Role in the Development of a Successful TAVR Program

Transcatheter aortic valve replacement (TAVR) is a Food and Drug Administration-approved means of treating symptomatic aortic stenosis in high-risk patients. A number of techniques to deliver valve prostheses are currently in practice, including transfemoral (TF), transapical, and transaortic approaches. Various disciplines are involved throughout this complex process. Our team includes a vascular surgeon, bringing greater experience in aortoiliac imaging, vascular access, and repair. We analyzed the role of a vascular surgeon during the selection process and throughout safe device delivery.

Source: Journal of Vascular Surgery - August 22, 2014 Category: Surgery Authors: Jeffrey Ranaudo, Ossama Reslan, Marc Cohen, Bruce Haik, Mark Russo, Paul Burns, Bruce J. Brener, Cindy Sturt Tags: Abstracts from the 2014 New England Society for Vascular Surgery/Eastern Vascular Society Joint Annual Meeting Source Type: research